AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 273: E831-E838, 1997;
0193-1849/97 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coker, R. H.
Right arrow Articles by Wasserman, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coker, R. H.
Right arrow Articles by Wasserman, D. H.
Vol. 273, Issue 5, E831-E838, November 1997

Role of hepatic alpha - and beta -adrenergic receptor stimulation on hepatic glucose production during heavy exercise

Robert H. Coker, Mahesh G. Krishna, D. Brooks Lacy, Deanna P. Bracy, and David H. Wasserman

Department of Molecular Physiology and Biophysics and Diabetes Research and Training Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232

The role of catecholamines in the control of hepatic glucose production was studied during heavy exercise in dogs, using a technique to selectively block hepatic alpha - and beta -adrenergic receptors. Surgery was done >16 days before the study, at which time catheters were implanted in the carotid artery, portal vein, and hepatic vein for sampling and the portal vein and vena cava for infusions. In addition, flow probes were implanted on the portal vein and hepatic artery. Each study consisted of a 100-min equilibration, a 30-min basal, a 20-min heavy exercise (~85% of maximum heart rate), a 30-min recovery, and a 30-min adrenergic blockade test period. Either saline (control; n = 7) or alpha  (phentolamine)- and beta  (propranolol)-adrenergic blockers (Blk; n = 6) were infused in the portal vein. In both groups, epinephrine (Epi) and norepinephrine (NE) were infused in the portal vein during the blockade test period to create supraphysiological levels at the liver. Isotope ([3-3H]glucose) dilution and arteriovenous differences were used to assess hepatic function. Arterial Epi, NE, glucagon, and insulin levels were similar during exercise in both groups. Endogenous glucose production (Ra) rose similarly during exercise to 7.9 ± 1.2 and 7.5 ± 2.0 mg · kg-1 · min-1 in control and Blk groups at time = 20 min. Net hepatic glucose output also rose to a similar rate in control and Blk groups with exercise. During the blockade test period, arterial plasma glucose and Ra rose to 164 ± 5 mg/dl and 12.0 ± 1.4 mg · kg-1 · min-1, respectively, but were essentially unchanged in Blk. The attenuated response to catecholamine infusion in Blk substantiates the effectiveness of the hepatic adrenergic blockade. In conclusion, these results show that direct hepatic adrenergic stimulation does not participate in the increase in Ra, even during the exaggerated sympathetic response to heavy exercise.

catecholamine; adrenergic blockade; endogenous glucose production


This article has been cited by other articles:


Home page
DiabetesHome page
R. H. Coker, Y. Koyama, J. C. Denny, R. C. Camacho, D. B. Lacy, and D. H. Wasserman
Prevention of Overt Hypoglycemia During Exercise: Stimulation of Endogenous Glucose Production Independent of Hepatic Catecholamine Action and Changes in Pancreatic Hormone Concentration
Diabetes, May 1, 2002; 51(5): 1310 - 1318.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. B. Marliss and M. Vranic
Intense Exercise Has Unique Effects on Both Insulin Release and Its Roles in Glucoregulation: Implications for Diabetes
Diabetes, February 1, 2002; 51(90001): S271 - 283.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. Braun, P. B. Rock, S. Zamudio, G. E. Wolfel, R. S. Mazzeo, S. R. Muza, C. S. Fulco, L. G. Moore, and G. E. Butterfield
Women at altitude: short-term exposure to hypoxia and/or {alpha}1-adrenergic blockade reduces insulin sensitivity
J Appl Physiol, August 1, 2001; 91(2): 623 - 631.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. H. Coker, L. Simonsen, J. Bulow, D. H. Wasserman, and M. Kjar
Stimulation of splanchnic glucose production during exercise in humans contains a glucagon-independent component
Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E918 - E927.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. J. Geor, K. W. Hinchcliff, and R. A. Sams
beta -Adrenergic blockade augments glucose utilization in horses during graded exercise
J Appl Physiol, September 1, 2000; 89(3): 1086 - 1098.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. H. Kreisman, N. A. Mew, M. Arsenault, S. J. Nessim, J. B. Halter, M. Vranic, and E. B. Marliss
Epinephrine infusion during moderate intensity exercise increases glucose production and uptake
Am J Physiol Endocrinol Metab, May 1, 2000; 278(5): E949 - E957.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. H. Coker, D. B. Lacy, P. E. Williams, and D. H. Wasserman
Hepatic alpha - and beta -adrenergic receptors are not essential for the increase in Ra during exercise in diabetes
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E444 - E451.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Howlett, M. Febbraio, and M. Hargreaves
Glucose production during strenuous exercise in humans: role of epinephrine
Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1130 - E1135.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online